Brain Tumor

News Brain Tumor

• New angle to combat malignant brain tumors in children

  A medulloblastoma is a malignant brain tumor that occurs primarily in children and is currently untreatable. Peter Carmeliet and his team (VIB-KU Leuven) joined forces with scientists at Massachusetts General Hospital in Harvard to study the role of the placental growth factor (PIGF) in the growth o more

• How does the immune system fight off threats to the brain?

  Like a police officer calling for backup while also keeping a strong hold on a suspected criminal, immune cells in the brain take a two-tier approach to fighting off a threat, new research from the University of Michigan Health System finds.For the first time, the scientists managed to capture that more

• BioInvent and ThromboGenics Announce the Start of New Study of Novel Antibody Anti-Cancer Agent TB-403 (Anti-PlGF) by Partner Roche

  BioInvent International AB  and co-development partner ThromboGenics NV announced that their partner Roche has dosed the first patient in a phase Ib/II study with the novel antibody anti-cancer agent TB-403 (RG7334). The trial is in patients with glioblastoma multiforme, the most common and aggressi more

Publications Brain Tumor

• Deciphering the 8q24.21 association for glioma

  We have previously identified tagSNPs at 8q24.21 influencing glioma risk. We have sought to fine-map the location of the functional basis of this association using data from four genome-wide association studies, comprising a total of 4147 glioma cases and 7435 controls. To improve marker density ac more

• Defining pseudoprogression in glioblastoma multiforme

  Background and purpose Pseudoprogression is a frequent phenomenon observed since the introduction of postoperative therapy with radiotherapy and temozolomide (RT/TMZ) in glioblastoma multiforme (GBM) patients. However, the criteria defining pseudoprogression, its incidence, the time of occurrenc more

• miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma

  by Soumya Alige Mahabala Rao, Arivazhagan Arimappamagan, Paritosh Pandey, Vani Santosh, Alangar Sathyaranjandas Hegde, Bangalore Ashwathnarayanara Chandramouli, Kumaravel Somasundaram Glioblastoma is one of the common types of primary brain tumors with a median survival of 12–15 months. The recep more

Market studies Brain Tumor

• Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Glioblastoma Multiforme (GBM), complete with latest updates, and spec more

• Brain Tumor – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Brain Tumor - Pipeline Review, H2 2012', provides an overview of the Brain Tumor therapeutic pipeline. This report provides information on the therapeutic development for Brain Tumor, complete with latest updates, and special features on late-stage and discon more

• Biobanks - 2012 Year Book

  GBI Research, the leading business intelligence provider, has released its latest report, “Biobanks - 2012 Year Book”. It provides key data, information and analysis of 37 of the world’s major biobanks. The report provides information on population-based biobanks, disease based biobanks, brain bioba more

Websites Brain Tumor